Translations:Dulaglutide/17/en: Difference between revisions
		
		
		
		Jump to navigation
		Jump to search
		
|  Importing a new version from external source | 
| (No difference) | 
Latest revision as of 10:29, 12 February 2024
History
The safety and effectiveness of dulaglutide were evaluated in six clinical trials in which 3,342 subjects with type 2 diabetes received dulaglutide. Subjects receiving dulaglutide had an improvement in their blood sugar control as observed with reductions in HbA1c level (hemoglobin A1c is a measure of blood sugar control).